Andrew D. Cansfield

425 citations

7 papers · 194 indexed · h-index 6

Co-authors: Jonathan D. Moore D.S. Williamson Alan Robertson Christine M. Richardson P. Dokurno C Torrance Martin J. Parratt Geraint L. Francis
Topics: Chronic Lymphocytic Leukemia Research (2 papers)Biochemical and Molecular Research (2 papers)Cancer-related Molecular Pathways (2 papers)
Cited by: Organic Chemistry Genetics Toxicology
Journals: Journal of Medicinal Chemistry Cell Cycle Bioorganic & Medicinal Chemistry Letters
Partner nations: United Kingdom United States India

In The Last Decade

Andrew D. Cansfield

7 papers receiving 191 citations

Peers

Countries citing papers authored by Andrew D. Cansfield

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Cansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Cansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Cansfield more than expected).

Fields of papers citing papers by Andrew D. Cansfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Cansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Cansfield. The network helps show where Andrew D. Cansfield may publish in the future.

Co-authorship network of co-authors of Andrew D. Cansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Cansfield. A scholar is included among the top collaborators of Andrew D. Cansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Cansfield. Andrew D. Cansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode 2022 ·ACS Medicinal Chemistry Letters ·Stacey M. Southall,Joydeep Banerjee,Jason Brown,(unknown),Andrew D. Cansfield,Julie E. Cansfield,Miles Congreve,G. Cseke,Francesca Deflorian,(unknown),(unknown),(unknown),(unknown),Gordon Saxty,(unknown)	1
2	Structure-Based Drug Discovery of N -(( R )-3-(7-Methyl-1 H -indazol-5-yl)-1-oxo-1-((( S )-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3- d ][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine 2020 ·Journal of Medicinal Chemistry ·(unknown),Mark A. Ator,Alastair Brown,Jason Brown,Andrew D. Cansfield,Julie E. Cansfield,J.A. Christopher,Miles Congreve,G. Cseke,Francesca Deflorian,Christopher R. Jones,Jonathan Mason,Alistair O’Brien,Gregory R. Ott,Mark Pickworth,Stacey M. Southall	13
3	CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model 2016 ·ACS Medicinal Chemistry Letters ·Andrew D. Cansfield,T. Ladduwahetty,(unknown),Katie Ellard,(unknown),Anthea Newton,(unknown),Gavin Bennett,Nico Zinn,Douglas W. Thomson,(unknown),(unknown),Oliver Rausch,Alan P. Watt,Giovanna Bergamini	14
4	SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Kathryn M. Bell,(unknown),Katie Ellard,Andrew D. Cansfield,(unknown),Warren Miller,Nigel G. Ramsden,Giovanna Bergamini,Gitte Neubauer	35
5	Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked 2008 ·Cell Cycle ·Simon Scrace,(unknown),Jenifer Borgognoni,Lan-Zhen Wang,Sarah K. Denny,(unknown),(unknown),Andrew D. Cansfield,Philip S. Jackson,(unknown),Nicola J. Curtin,David R. Newell,D.S. Williamson,Jonathan D. Moore	15
6	Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christine M. Richardson,D.S. Williamson,Martin J. Parratt,Jenifer Borgognoni,Andrew D. Cansfield,P. Dokurno,Geraint L. Francis,Rob Howes,Jonathan D. Moore,James B. Murray,Alan Robertson,A.E. Surgenor,C Torrance	56
7	Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2 2005 ·Bioorganic & Medicinal Chemistry Letters ·D.S. Williamson,Martin J. Parratt,Justin Bower,Jonathan D. Moore,Christine M. Richardson,P. Dokurno,Andrew D. Cansfield,Geraint L. Francis,(unknown),Rob Howes,Philip S. Jackson,(unknown),James B. Murray,(unknown),(unknown),Alan Robertson,A.E. Surgenor,C Torrance	60

About Andrew D. Cansfield

Andrew D. Cansfield is a scholar working on Genetics, Cell Biology and Oncology, having authored 7 papers that have together received 194 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Biochemical and Molecular Research (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Organic Chemistry (88 citations), Genetics (23 citations) and Toxicology (6 citations). Andrew D. Cansfield has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Jonathan D. Moore, D.S. Williamson, Alan Robertson, Christine M. Richardson, P. Dokurno, C Torrance, Martin J. Parratt, Geraint L. Francis, Rob Howes and A.E. Surgenor. Their work appears in journals such as Journal of Medicinal Chemistry, Cell Cycle and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact